| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vaxcyte, Inc. (PCVX) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 37 sells. PCVX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 496.9K | $25.58M | - | |
| COO | 160.7K | $8.28M | -2,250 | |
| CFO | 104.4K | $5.37M | - | |
| Other | 76.0K | $3.91M | - | |
| VP | 29.4K | $1.51M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 3, 2025 | Wassil Jim53 | Chief Operating Officer | Sale+OE | 8,000 | $86.22 | $689,790.43 | -1.3% | -59.6% | -34.3% | |
| Jan 21, 2025 | Guggenhime Andrew46 | President And CFO | Sale+OE | 8,000 | $86.51 | $692,100.57 | -2.4% | -65.5% | -43.0% | |
| Jan 15, 2025 | Loxam Teri | Director | Sale+OE | 6,250 | $85.11 | $531,962.92 | -7.1% | -66.1% | -46.2% | |
| Jan 6, 2025 | Eydelman Mikhail67 | SVP, Gen Counsel &Corp Sec | Sale+OE | 5,000 | $85.58 | $427,922.80 | -5.3% | -62.2% | -47.8% | |
| Jan 2, 2025 | Wassil Jim53 | Chief Operating Officer | Sale+OE | 8,000 | $83.66 | $669,266.91 | -1.3% | -59.6% | -44.2% | |
| Dec 18, 2024 | Guggenhime Andrew46 | President And CFO | Sale+OE | 8,000 | $88.78 | $710,248.58 | -1.8% | -12.9% | -49.0% | |
| Dec 9, 2024 | Pickering Grant50 | Chief Executive Officer | Sell | 2,366 | $92.25 | $218,252.88 | -0.4% | -25.2% | -51.4% | |
| Dec 5, 2024 | Eydelman Mikhail67 | SVP, Gen Counsel &Corp Sec | Sale+OE | 5,000 | $91.49 | $457,433.92 | -5.3% | -17.9% | -48.4% | |
| Dec 2, 2024 | Wassil Jim53 | Chief Operating Officer | Sale+OE | 8,000 | $92.49 | $739,884.53 | -1.3% | -21.3% | -51.2% | |
| Dec 2, 2024 | Pickering Grant50 | Chief Executive Officer | Sell | 15,000 | $92.45 | $1,386,794.41 | -1.1% | -21.3% | -51.2% |